Literature DB >> 8908664

Frequency volume charts: an indispensable part of lower urinary tract assessment.

P Abrams1, B Klevmark.   

Abstract

Frequency volume charts (FV charts) are widely used by those interested in lower urinary tract function. However, there has been little systematic work on the value and design of FV charts as they have evolved over the years as clinical tools rather than as research instruments. Although FV chart design has developed over the last 20 years, there is no standard and charts vary from simple frequency charts up to urinary diaries which record not only frequency, volume, urge episodes, pad usage and fluid intake, but also the patients' activities in relation to their lower urinary tract symptoms. Studies have shown that charts can be relatively complex and still be acceptable to patients, providing proper instruction is given, either by written advice or at face to face interviews. The correlations between the answers to simple questions concerning frequency and nocturia and the data extracted from FV charts are variably strong: nocturia, pad usage and incontinence episodes correlate well, whereas urinary frequency correlates less closely. A number of conclusions on frequency volume charts can be made. The chart is best kept for 7 days in order to cover both work and leisure periods. The daytime should be separated from the night-time, and this is particularly important in assessing older patients with possible nocturnal polyuria. Addition of voided volume measurement to the frequency chart allows the construction of a simple classification of FV charts. This classification links the characteristics seen on the FV charts with particular lower urinary tract dysfunctions. Whilst this classification gives a guide to the patient's possible diagnosis, the overlap between symptomatic groups and normal controls is large. FV charts have an important role in objectively, recording patients' symptoms, both as a base line and after therapeutic interventions. They are particularly important in everyday clinical use as a vital part of bladder training. In the research field they are important in providing objective evidence of changes in subjective symptoms in a treatment group as opposed to the placebo group. They have been particularly valuable in the evaluation of new drugs for the treatment of detrusor overactivity and benign prostatic obstruction. Most FV charts rely on pen and paper. However in the computer age the possibility of computerising the FV chart is attractive, but as yet not fully evaluated. At present it is advised that a simple frequency volume chart with the additional recording of incontinent episodes, pad usage and overall assessment of fluid intake is used for routine clinical use. In a research setting urinary diaries may add significant additional information, allowing a more complete evaluation of novel therapies.

Entities:  

Mesh:

Year:  1996        PMID: 8908664

Source DB:  PubMed          Journal:  Scand J Urol Nephrol Suppl        ISSN: 0300-8886


  15 in total

Review 1.  Measuring urgency in clinical practice.

Authors:  Roger R Dmochowski; Mary P FitzGerald; Jean-Jacques Wyndaele
Journal:  World J Urol       Date:  2009-08-27       Impact factor: 4.226

2.  The Larsson frequency/volume chart is not a substitute for cystometry in the investigation of women with urinary incontinence.

Authors:  D G Tincello; D H Richmond
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

3.  The overactive bladder.

Authors:  Richard Foon; Marcus J Drake
Journal:  Ther Adv Urol       Date:  2010-08

Review 4.  [Diagnostics of benign prostate syndrome].

Authors:  M Seitz; A Herlemann; G Magistro; C G Stief
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

5.  Impact of stress urinary incontinence and overactive bladder on micturition patterns and health-related quality of life.

Authors:  Seung-June Oh; Ja Hyeon Ku
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-31

6.  Non invasive urodynamic assessment in children--are they reliable? Validation of non-invasive urodynamics in children with functional voiding disorders.

Authors:  H Ravi Ramamurthy; Madhuri Kanitkar
Journal:  Indian J Pediatr       Date:  2010-09-16       Impact factor: 1.967

Review 7.  Management of overactive bladder.

Authors:  Dev M Gulur; Marcus J Drake
Journal:  Nat Rev Urol       Date:  2010-10       Impact factor: 14.432

8.  Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: a preliminary study.

Authors:  Yun Seob Song; Ja Hyeon Ku
Journal:  Int Urol Nephrol       Date:  2007-07-03       Impact factor: 2.370

9.  Nocturia reported in nightly sleep diaries: common occurrence with significant implications?

Authors:  Donald L Bliwise; Leah Friedman; Beatriz Hernandez; Jamie M Zeitzer; Clete A Kushida; Jerome A Yesavage
Journal:  Health Psychol       Date:  2013-11-18       Impact factor: 4.267

10.  Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice.

Authors:  G Ghoniem; E Stanford; K Kenton; C Achtari; R Goldberg; T Mascarenhas; M Parekh; K Tamussino; S Tosson; G Lose; E Petri
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.